ROME, ITALY — Using the factor Xa inhibitor edoxaban (Savaysa/Lixiana, Daiichi Sankyo) to anticoagulate patients about to undergo electrical cardioversion for their atrial fibrillation (AF) seems ...
Restoring a normal heart rhythm can hugely improve a patient's quality of life. SoGlos discovers more about a new treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback